A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye

Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial

(2016) Andrea Leonardi et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Topical cyclosporine: are all indications justified?: Table 1

(2014) Pasquale Aragona   BRITISH JOURNAL OF OPHTHALMOLOGY

Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – A randomised comparative study

(2014) M. Amrane et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting

(2013) Christophe Baudouin et al.   Ocular Surface

The Association Between symptoms of Discomfort and signs in Dry Eye

(2012) Michael E. Johnson   Ocular Surface

Rationale for anti-inflammatory therapy in dry eye syndrome

(2009) CS De Paiva et al.   ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses

(2009) Eric Donnenfeld et al.   SURVEY OF OPHTHALMOLOGY

Advances in Understanding and Managing Dry Eye Disease

(2008) Michael A. Lemp   AMERICAN JOURNAL OF OPHTHALMOLOGY

Glycan structures of ocular surface mucins in man, rabbit and dog display species differences

(2008) Louise Royle et al.   GLYCOCONJUGATE JOURNAL

Severe impairment of health-related quality of life in patients suffering from ocular surface diseases

(2008) C. Baudouin et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Treatment of Dry Eye Disease by the Non-Ophthalmologist

(2008) Gary N. Foulks   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA